Expression of CD147 and Lewis y antigen in ovarian cancer and their relationship to drug resistance.
- Published in:
- Medical Oncology, 2014, v. 31, n. 5, p. 1, doi. 10.1007/s12032-014-0920-9
- By:
- Publication type:
- Article
Works by Liu, Dawo
Results: 14
1
2
Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2013, v. 32, n. 1, p. 1, doi. 10.1186/1756-9966-32-36
- By:
- Publication type:
- Article
3
Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression.
- Published in:
- International Journal of Molecular Medicine, 2017, v. 40, n. 2, p. 293, doi. 10.3892/ijmm.2017.3009
- By:
- Publication type:
- Article
4
c-Fos mediates α1, 2-fucosyltransferase 1 and Lewis y expression in response to TGF-β1 in ovarian cancer.
- Published in:
- Oncology Reports, 2017, v. 38, n. 6, p. 3355, doi. 10.3892/or.2017.6052
- By:
- Publication type:
- Article
5
Human epididymis protein 4 in association with Annexin II promotes invasion and metastasis of ovarian cancer cells.
- Published in:
- Molecular Cancer, 2014, v. 13, p. 1, doi. 10.1186/1476-4598-13-243
- By:
- Publication type:
- Article
6
Interaction of HE4 and ANXA2 exists in various malignant cells—HE4–ANXA2–MMP2 protein complex promotes cell migration.
- Published in:
- Cancer Cell International, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12935-019-0864-4
- By:
- Publication type:
- Article
7
Autophagy-independent enhancing effects of Beclin 1 on cytotoxicity of ovarian cancer cells mediated by proteasome inhibitors.
- Published in:
- BMC Cancer, 2012, v. 12, n. 1, p. 622, doi. 10.1186/1471-2407-12-622
- By:
- Publication type:
- Article
8
Beclin 1 Expression in Ovarian Tissues and Its Effects on Ovarian Cancer Prognosis.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 4, p. 5292, doi. 10.3390/ijms15045292
- By:
- Publication type:
- Article
9
Elevated Levels of Lewis Y and Integrin a5ß1 Correlate with Chemotherapeutic Drug Resistance in Epithelial Ovarian Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2012, v. 13, n. 12, p. 15588, doi. 10.3390/ijms131215588
- By:
- Publication type:
- Article
10
Lewis y Regulate Cell Cycle Related Factors in Ovarian Carcinoma Cell RMG-I in Vitro via ERK and Akt Signaling Pathways.
- Published in:
- International Journal of Molecular Sciences, 2012, v. 13, n. 1, p. 828, doi. 10.3390/ijms13010828
- By:
- Publication type:
- Article
11
The Stimulation of IGF-1R Expression by Lewis(y) Antigen Provides a Powerful Development Mechanism of Epithelial Ovarian Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2011, v. 12, n. 10, p. 6781, doi. 10.3390/ijms12106781
- By:
- Publication type:
- Article
12
HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways.
- Published in:
- BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10248-5
- By:
- Publication type:
- Article
13
Co-Expression of Lewis y Antigen with Human Epididymis Protein 4 in Ovarian Epithelial Carcinoma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 7, p. 1, doi. 10.1371/journal.pone.0068994
- By:
- Publication type:
- Article
14
High Expression of Lewis y Antigen and CD44 Is Correlated with Resistance to Chemotherapy in Epithelial Ovarian Cancers.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0057250
- By:
- Publication type:
- Article